Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | OTC | P00480 | 1/20 | 0.32 |
| ▸ | NPY4R | P50391 | 8/20 | 0.32 |
| ▸ | NPY1R | P25929 | 5/20 | 0.32 |
| ▸ | NPY2R | P49146 | 3/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.32 |
| ▸ | ALB | P02768 | 1/20 | 0.31 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.31 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4273557 | 1.00 | ALOX15 (0.34) | ALOX15MEN1KMT2ACYP1A2SMN1; SMN2 | |
| SCHEMBL2673036 | 0.87 | ALOX15 (0.36) | ALOX15MEN1KMT2ACYP1A2SMN1; SMN2 | |
| SCHEMBL2673040 | 0.87 | ALOX15 (0.36) | ALOX15MEN1KMT2ACYP1A2SMN1; SMN2 | |
| SCHEMBL30581622 | 0.86 | FOLH1 (0.36) | ALOX15MEN1KMT2ACYP1A2SMN1; SMN2 | |
| SCHEMBL28406813 | 0.86 | FOLH1 (0.36) | ALOX15MEN1KMT2ACYP1A2SMN1; SMN2 | |
| SCHEMBL4191476 | 0.85 | OTC (0.33) | ALOX15MEN1KMT2ACYP1A2SMN1; SMN2 | |
| SCHEMBL4191486 | 0.85 | OTC (0.33) | ALOX15MEN1KMT2ACYP1A2SMN1; SMN2 | |
| SCHEMBL160690 | 0.84 | NOS2 (0.38) | ALOX15MEN1KMT2ACYP1A2SMN1; SMN2 | |
| SCHEMBL196827 | 0.84 | NOS2 (0.38) | ALOX15MEN1KMT2ACYP1A2SMN1; SMN2 | |
| SCHEMBL288819 | 0.84 | NOS2 (0.38) | ALOX15MEN1KMT2ACYP1A2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117355321-A | Performance enhancing excipients and methods for reducing viscosity and improving stability of biological agents | 安万托特性材料股份有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-117355321-A | Performance enhancing excipients and methods for reducing viscosity and improving stability of biological agents | 安万托特性材料股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-117355321-A | Performance enhancing excipients and methods for reducing viscosity and improving stability of biological agents | 安万托特性材料股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| US-7608250-B2 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2009-10-27 | — | — | US | disclosed |
| US-20060029626-A1 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2006-02-09 | — | — | US | disclosed |
| US-20030165448-A1 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030165448-A1 | Cosmetic composition | CUTA, ARGLU1, ASS1 | ALOX15 1079/4885MEN1 291/4885KMT2A 1775/4885 |
| US-20060029626-A1 | Cosmetic composition | CUTA, NGLY1, ARG1 | ALOX15 686/4885MEN1 189/4885KMT2A 1769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.